biopharmaceutical company that manufactures an immunotherapy for prostate cancer
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | DENDREON PHARMACEUTICALS, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $59,650 | |
| 2025 | DENDREON PHARMACEUTICALS, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $59,650 | |
| 2025 | DENDREON PHARMACEUTICALS, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $59,650 | |
| 2025 | DENDREON PHARMACEUTICALS, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $58,787 | |
| 2025 | DENDREON PHARMACEUTICALS, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $60,147 | |
| 2024 | DENDREON PHARMACEUTICALS, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $67,562 | |
| 2024 | DENDREON PHARMACEUTICALS, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $67,987 | |
| 2024 | DENDREON PHARMACEUTICALS, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $68,072 | |
| 2024 | DENDREON PHARMACEUTICALS, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $67,477 | |
| 2023 | DENDREON PHARMACEUTICALS, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $104,223 |
| Client | Filings | Total Income |
|---|---|---|
| DENDREON PHARMACEUTICALS, LLC | 32 | — |
| Name | Disclosed Prior Position |
|---|---|
| ANDREW SAELENS |